ATLAB Pharma

About ATLAB Pharma

ATLAB Pharma SAS is a privately-owned biotechnology company headquartered in Nantes, France. ATLAB is developing a pipeline of innovative anti-cancer radiopharmaceuticals based on monoclonal antibodies coupled to the beta-emitting radioisotope Lutetium-177 and to the alpha-emitting radioisotope Astatine-211.
YEAR FOUNDED:
2008
LEADERSHIP:
Founder: Jean-François Chatal
President: Jean-Marc Le Doussal